The present invention relates to a lentil extract with surprising cholesterol lowering and prebiotic effects that make it particularly useful in therapeutic applications and as a nutraceutical. Said lentil extract is characterized by the presence of soyasaponin I in the range of 50 to 300 mg kg 1 and soyasaponin g in the range of 0.5 to 5 mg kg 1. The process for the production of said extract and its therapeutic and nutraceutical uses are also within the scope of the present invention.
Lentil extract with cholesterol lowering and prebiotic activity
Gianni Sagratini;Sauro Vittori;Giovanni Caprioli;Carlo Cifani;Maria Vittoria Micioni di Bonaventura;Alberto Cresci;
2017-01-01
Abstract
The present invention relates to a lentil extract with surprising cholesterol lowering and prebiotic effects that make it particularly useful in therapeutic applications and as a nutraceutical. Said lentil extract is characterized by the presence of soyasaponin I in the range of 50 to 300 mg kg 1 and soyasaponin g in the range of 0.5 to 5 mg kg 1. The process for the production of said extract and its therapeutic and nutraceutical uses are also within the scope of the present invention.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
